Insider Transactions in Q4 2023 at Phreesia, Inc. (PHR)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
255
+0.22%
|
$4,845
$19.68 P/Share
|
|
Dec 19
2023
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
118
-0.29%
|
$2,714
$23.72 P/Share
|
|
Dec 19
2023
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
25
-0.33%
|
$575
$23.72 P/Share
|
|
Dec 18
2023
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
234
-2.99%
|
$5,382
$23.15 P/Share
|
|
Nov 01
2023
|
Janet Gunzburg Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
298
-0.73%
|
$3,874
$13.38 P/Share
|
|
Oct 31
2023
|
Evan Roberts Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+3.72%
|
$60,000
$2.03 P/Share
|
|
Oct 31
2023
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
732
+1.59%
|
$9,516
$13.66 P/Share
|
|
Oct 31
2023
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
732
+2.32%
|
$9,516
$13.66 P/Share
|
|
Oct 31
2023
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
732
+2.7%
|
$9,516
$13.66 P/Share
|
|
Oct 16
2023
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
861
-1.0%
|
$13,776
$16.61 P/Share
|
|
Oct 16
2023
|
Michael J. Davidoff SVP, Payer Business |
SELL
Open market or private sale
|
Direct |
1,198
-1.28%
|
$19,168
$16.61 P/Share
|
|
Oct 16
2023
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,297
-1.12%
|
$20,752
$16.61 P/Share
|
|
Oct 16
2023
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
665
-0.56%
|
$10,640
$16.61 P/Share
|
|
Oct 16
2023
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
2,078
-0.96%
|
$33,248
$16.61 P/Share
|
|
Oct 16
2023
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,971
-0.26%
|
$31,536
$16.61 P/Share
|
|
Oct 16
2023
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,295
-0.26%
|
$52,720
$16.61 P/Share
|